372 related articles for article (PubMed ID: 25927031)
1. Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure.
Hu CD; Choo R; Huang J
Front Oncol; 2015; 5():90. PubMed ID: 25927031
[TBL] [Abstract][Full Text] [Related]
2. Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells.
Suarez CD; Deng X; Hu CD
Am J Cancer Res; 2014; 4(6):850-61. PubMed ID: 25520873
[TBL] [Abstract][Full Text] [Related]
3. Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.
Deng X; Elzey BD; Poulson JM; Morrison WB; Ko SC; Hahn NM; Ratliff TL; Hu CD
Am J Cancer Res; 2011; 1(7):834-44. PubMed ID: 22016831
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation.
Asberry AM; Liu S; Nam HS; Deng X; Wan J; Hu CD
Comput Struct Biotechnol J; 2022; 20():5873-5885. PubMed ID: 36382181
[TBL] [Abstract][Full Text] [Related]
5. Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
Owens JL; Beketova E; Liu S; Shen Q; Pawar JS; Asberry AM; Yang J; Deng X; Elzey BD; Ratliff TL; Cheng L; Choo R; Citrin DE; Polascik TJ; Wang B; Huang J; Li C; Wan J; Hu CD
Mol Cancer Ther; 2022 Mar; 21(3):448-459. PubMed ID: 35027481
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine pathogenesis in adenocarcinoma of the prostate.
Hansson J; Abrahamsson PA
Ann Oncol; 2001; 12 Suppl 2():S145-52. PubMed ID: 11762343
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.
Conteduca V; Aieta M; Amadori D; De Giorgi U
Crit Rev Oncol Hematol; 2014 Oct; 92(1):11-24. PubMed ID: 24952997
[TBL] [Abstract][Full Text] [Related]
8. JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer.
Pawar JS; Al-Amin MY; Hu CD
Front Oncol; 2023; 13():1126482. PubMed ID: 36959798
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
11. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in the progression of prostate cancer.
Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H
Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
Bonkhoff H; Fixemer T
Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
[TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of prostate cancer with neuroendocrine differentiation.
Li Q; Zhang CS; Zhang Y
Chin J Cancer Res; 2016 Feb; 28(1):122-9. PubMed ID: 27041934
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer.
Akoto T; Bhagirath D; Saini S
Cancer Drug Resist; 2020; 3(4):804-818. PubMed ID: 33426506
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.
Deng X; Liu H; Huang J; Cheng L; Keller ET; Parsons SJ; Hu CD
Cancer Res; 2008 Dec; 68(23):9663-70. PubMed ID: 19047143
[TBL] [Abstract][Full Text] [Related]
17. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.
Lee GT; Kwon SJ; Lee JH; Jeon SS; Jang KT; Choi HY; Lee HM; Kim WJ; Lee DH; Kim IY
Prostate; 2011 Oct; 71(14):1525-37. PubMed ID: 21374653
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
19. Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation.
Marchiani S; Tamburrino L; Nesi G; Paglierani M; Gelmini S; Orlando C; Maggi M; Forti G; Baldi E
Int J Androl; 2010 Dec; 33(6):784-93. PubMed ID: 20088946
[TBL] [Abstract][Full Text] [Related]
20. GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.
Sang M; Hulsurkar M; Zhang X; Song H; Zheng D; Zhang Y; Li M; Xu J; Zhang S; Ittmann M; Li W
Oncotarget; 2016 Jul; 7(29):45171-45185. PubMed ID: 27191986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
